Thromboembolic events in hospitalised patients with COVID-19: ecological assessment with a scoping review
Objectives Thrombosis is a common complication of the novel COVID-19. Pre-COVID-19 studies reported racial differences in the risk of developing thrombosis. This study aimed to describe the geographical variations in the reported incidences and outcomes of thromboembolic events and thromboprophylaxi...
Main Authors: | Tomoko Fujii, Saori Kurata, Naoki Miyayama, Kenta Ogawa, Kaede Watanabe, Kengo Asano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/1/e066218.full |
Similar Items
-
Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
by: Shinya Kameda, et al.
Published: (2023-01-01) -
Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
by: Shinya Kameda, et al.
Published: (2023-01-01) -
Thromboembolic Events in Patients with Influenza: A Scoping Review
by: Raffaella Rubino, et al.
Published: (2022-12-01) -
Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension
by: Pavel Jansa, et al.
Published: (2022-10-01) -
Prevention of Thromboembolic Events in Patients with COVID-19
by: Surbhi Warrior, et al.
Published: (2021-07-01)